Aidapak Recalls Phosphorus Tablets Due to Potential Label Mixup
Aidapak Services is recalling 250 mg Phosphorus tablets because they may be mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (label mixup) without reported illnesses or injuries, which aligns with the rubric for moderate severity involving minor labeling errors or low-risk contamination.
Plain-English summary
Aidapak Services, LLC is recalling 1,000 tablets of PHOSPHORUS Tablet, 250 mg (NDC 64980010401) due to a potential label mixup. The recall involves repacked drugs that were distributed in Arizona, California, Oregon, and Washington.
The FDA classifies this as a Class II recall because the product may be mislabeled as several other prescription medications, including Citalopram, Venlafaxine HCl, Nitrofurantoin Macrocrystals, and Trazodone HCl. The source text does not report any illnesses or injuries associated with this labeling error.
Consumers and healthcare providers should check their inventory for the specific pedigree codes and expiration dates listed in the recall notice. If the product is found, it should be returned to the distributor or the FDA as directed.
The recalled product
- Product
- PHOSPHORUS Tablet, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64980010401
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 1,000
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (15)
- PHOSPHORUS Tablet
- 250 mg has the following codes Pedigree: AD56916_1
- EXP: 5/21/2014
- Pedigree: W002534
- EXP: 6/3/2014
- Pedigree: AD25452_7
- EXP: 5/3/2014
- Pedigree: AD54498_1
- EXP: 5/20/2014
- Pedigree: W003997
- EXP: 7/1/2014
- Pedigree: AD46300_8
- EXP: 5/15/2014
- Pedigree: AD70639_10
- EXP: 5/29/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModeratePotassium Acid Phosphate Tablets Recalled for Potential Label Mixup
FDA (Drugs) · 2014-01-29
- SevereAidapak Recalls Aspirin Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Dutasteride Capsules Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Methocarbamol Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Potassium Acid Phosphate Tablets Due to Labeling Error
FDA (Drugs) · 2014-01-29
- HighAidapak Recalls Acyclovir Capsules Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-29